7 results loaded, newest first. End of these results.
News 2026-09-17 11:42 UTC
MergerBrief Daily: Deal News INDV/SUPN: Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend (PR) Curium/LNTH: Letter to Shareholders Urging Vote For Merger (Proxy) Wynnchurch/LXFR: ESPP Offer Period Shortened to September 30 Due to Pending Acquisition; Close mid to late November (Proxy) AWK/WTRG: AWCC Prices
News 2026-09-16 11:41 UTC
MergerBrief Daily: Deal News TEM/PSNL: Excerpts from Morgan Stanley Healthcare Conference transcript; Personalis acquisition rationale discussed (PR) MITT/CHMI: Form S-4 Filed (S-4) JBS/PPC: JBS S.A. Enters Association Agreement to Form JBS Viva Leather Joint Venture (PR) AWK/WTRG: AWK Note Offering (Filing) Mapfre S.A
News 2026-08-04 10:04 UTC
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better se
News 2026-08-03 14:44 UTC
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) and Indivior Pharmaceuticals Inc. (NASDAQ: INDV ) on Monday agreed to unite through a tax-free all-stock merger of equals, forming a central nervous system (CNS) biopharmaceutical company. The combined business will operate as Supernus and trade on the Nasdaq Global Market
News 2026-08-03 12:26 UTC
Supernus and Indivior merge to create CNS biopharmaceutical leader
News 2026-08-03 10:33 UTC
SUPN and INDV agree to merge
News 2026-08-03 10:31 UTC
SUPN INDV Supernus Pharmaceuticals and Indivior Pharmaceuticals to merge, creating a diversified Cns biopharmaceutical leader with significant scale Supernus Pharmaceuticals Inc - combined entity to be named Supernus, Inc. and Jack khattar to serve as President and Chief Executive Officer - Definitive agreement to comb